Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

09/02/2022 06:30

Feb 9 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             14.29               12.99            17.41    
                 (+10.0 pct)         (-2.7 pct)       (-0.5 pct)  
  Operating          1.09              748 mln          855 mln   
                 (+45.2 pct)         (+2.5 pct)       (-25.1 pct) 
  Recurring          1.14              759 mln          957 mln   
                 (+50.1 pct)         (-0.5 pct)       (-19.4 pct) 
  Net              661 mln             483 mln          574 mln   
                 (+36.9 pct)         (-2.5 pct)       (-27.7 pct) 
  EPS            193.96 yen          141.17 yen       167.73 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T